Chapter published in:
Argumentation across Communities of Practice: Multi-disciplinary perspectives
Edited by Cornelia Ilie and Giuliana Garzone
[Argumentation in Context 10] 2017
► pp. 197228
References

References

Barnard, D.
(2002) In the High Court of South Africa, Case no 4138/98: The Global Politics of Access to Low-Cost Aids Drugs in Poor Countries. Kennedy Institute of Ethics Journal, 12 (2), 159–174. CrossrefGoogle Scholar
Barner, M.
(2007) Be a Socially Responsible Corporation. Harvard Business Review. 85 (7), 59–60.Google Scholar
Blindheim, B. -T.
(2010) Towards a Convergent Institutional Perspective on Corporate Social Responsibility. PhD Dissertation, University of Stavanger, Norway. Available at http://​brage​.bibsys​.no​/uis​/bitstream​/URN:NBN:no​-bibsys​_brage​_13406​/1​/Blindheim,%20Bj%C3%B8rn​-Tore%20PhD​.pdf.
Bowen, H. R.
(1953) Social Responsibilities of the Businessman. New York: Harper and Brothers.Google Scholar
Burr, V.
(2003) (2nd edition). Social Constructionism. London: Routledge.Google Scholar
Carroll, A. B.
(1979) A Three-Dimensional Conceptual Model of Corporate Social Performance. Academy of Management Review, 4 (4), 497–505.Google Scholar
(1999) Corporate Social Responsibility: Evolution of a Definitional Construct. Business and Society, 38 (3), 268–95. CrossrefGoogle Scholar
Catenaccio, P. & Degano C.
(2011) Corporate Social Responsibility as a Key to the Representation of Corporate Identity. The Case of Novartis. In Bhatia, Vijay K. / Evangelisti Allori, Paola (Eds), Discourse and Identity in the Professions. Legal, Corporate and Institutional Citizenship (pp. 79–102). Bern: Peter Lang.Google Scholar
Catenaccio, P.
(2012) Understanding CSR Discourse. Insights from Linguistics and Discourse Analysis. Milano: Arcipelago.Google Scholar
Chouliaraki, L. & Fairclough, N.
(1999) Discourse in Late Modernity. Rethinking Critical Discourse Analysis. Edinburgh: Edinburgh University Press.Google Scholar
Deegan, C., Rankin, M., Tobin, J.
(2002) An examination of the Corporate Social and environmental disclosures of BHP from 1983–1997. Accounting, Auditing and Accountability Journal, 15 (3), 312–343. CrossrefGoogle Scholar
Deegan, C. (2002) The Legitimising Effect of Social and Environmental Disclosures – A Theoretical Foundation, Accounting, Auditing and Accountability Journal, 15 (3), 282–311. CrossrefGoogle Scholar
Degano, C.
(2012) Discourse Analysis, Argumentation Theory and Corpora. An Integrated Approach. Milano: Archipelago.Google Scholar
Dhanarajan, S.
(2005) Managing Ethical Standards: When Rhetoric Meets Reality. Development in Practice, 15 (3), 529–538. CrossrefGoogle Scholar
Donaldson, T. & Dunfee, T. W.
(1994) Towards a Unified Conception of Business Ethics: Integrative Social Contracts Theory. Academy of Management Review, 1 (2), 252–285.Google Scholar
Donaldson, T.
(1984) Case Studies in Business Ethics. Englewood Cliffs, NJ: Prentice Hall.Google Scholar
Edgar, A.
(2013) The Dominance of Big Pharma: Power. Medical Health and Care Philosophy, 16, 295–304. CrossrefGoogle Scholar
Eemeren, F. H. van, Grootendorst, R. & Snoeck Henkemans, F.
(2002) Argumentation: Analysis, Evaluation, Presentation. Mahwah, NJ: Lawrence Erlbaum.Google Scholar
Eemeren, F. H. van, & Grootendorst, R.
(1992) Argumentation, Communication, and Fallacies. Hillsdale, N.J.: Erlbaum.Google Scholar
(2004) A Systematic Theory of Argumentation. Amsterdam: SicSat.Google Scholar
Eemeren, F. H. van, Houtlosser, P. & Snoeck Henkemans, A. F.
(2007) Argumentative Indicators in Discourse. A Pragma-Dalectical Study. Dordrecht: Springer Verlag. CrossrefGoogle Scholar
Eemeren, F. H. van
(2010) Strategic Maneuvering in Argumentative Discourse. Amsterdam: Benjamins. CrossrefGoogle Scholar
Faulk, S. & Usunier, J. -C.
(2009) AIDS and Business. New York: Routlege.Google Scholar
Fisher III, W. W. / Rigamont, C. P.
(2005) The South Africa AIDS Controversy. A Case Study in Patent Law and Policy. Harvard Law School 3. Available at https://​cyber​.harvard​.edu​/people​/tfisher​/South%20Africa​.pdf.
Freeman, R. E.
(1984) Strategic Management: A Stakeholder Approach. Boston, MA: Pitman.Google Scholar
Goffman, E.
(1974) Frame Analysis: An Essay on the Organization of Experience. London: Harper and Row.Google Scholar
Gond, J. -P., Palazzo, G. & Basu, K.
(2009) Reconsidering Instrumental Corporate Social Responsibility through the Mafia Metaphor. Business Ethics Quarterly, 19(1), 57–85. CrossrefGoogle Scholar
Grayson, D. & Hodges, A.
(2004) Corporate Social Opportunity. Sheffield: Greenleaf Publishing.Google Scholar
Halbert, D.
(2002) Moralized Discourses: South Africa’s Intellectual Property Fight for Access to AIDS Drugs. Seattle Journal of Social Justice, 1 (2), 257–295.Google Scholar
Hasbani, M. & Bréton, G.
(2013) Restoring social legitimacy: discursive strategies used by a pharmaceutical industry leader. Society and Business Review, 8 (1), 71–89. CrossrefGoogle Scholar
Hoen, E. F. M.
(2009) The Global Politics of Pharmaceutical Monopoly Power. Drug Patents, Access, Innovation and the Application of the WTO Doha Declaration on TRIPS and Public Health. Diemen, The Netherlands: AMB Publishers.Google Scholar
Hooghiemstra, R.
(2000) Corporate communication and impression management: New perspectives why companies engage in corporate social reporting. Journal of Business Ethics, 27 (1/2), 55–68. CrossrefGoogle Scholar
(2008) Promotion and Protection of All Human Rights, Civil, Political, Economic, Social and Cultural Rights, including the Right to Development. Protect, Respect and Remedy: a Framework for Business and Human Rights. Report of the Special Representative of the Secretary-General on the issue of human rights and transnational corporations and other business enterprises, John Ruggie A/HRC/8/5, April 7th, 2008.Google Scholar
Hunston. S. & Thompson, G.
(2001) Evaluation in Text. Authorial Stance and the Construction of Discourse. Oxford: Oxford University Press.Google Scholar
Iețcu-Fairclough, I.
(2008) Legitimation and strategic maneuvering in the political field. Argumentation, 22, 399–417. CrossrefGoogle Scholar
Ihnen, C. & Richardson, J.
(2011) On combining pragma-dialectics with critical discourse analysis. In In E. T. Feteris, B. J. Garssen & A. F. Snoeck Henkemans (Eds.) Keeping in Touch with Pragma-dialectics. In Honor of Frans H. van Eemeren (pp. 231–244). Amsterdam: John Benjamins. CrossrefGoogle Scholar
Ilie, Cornelia
(2009) Strategies of Refutation by Definition: A Pragma-Rhetorical Approach to Refutations in a Public Speech. In F. H. van Eemeren & B. Garssen (Eds) Pondering on Problems of Argumentation. New York: Springer Verlag, (pp. 35–51). CrossrefGoogle Scholar
Illingworth, P.
(2012) Corporate Social Responsibility and the Right to Essential Medicines. In L. Forman & J. L. Kohler (Eds), Access to Medicines as a Human Right (pp. 75–90). Toronto: University of Toronto Press.Google Scholar
Kahneman, D. & Tversky, A.
(Eds) (2000) Choices, Values and Frames. New York, NY: Cambridge University Press.Google Scholar
Karon, T.
(2001) AIDS Drugs Case Puts Our Ideas About Medicine on Trial. Time, Mar 5, 2001. http://​content​.time​.com​/time​/world​/article​/0,8599,101494,00​.html.
Kennedy, C. R., Harris, F. H. & Lord, M.
(2004) Integrating Public Policy and Public Affairs in a Pharmaceutical Marketing Program: The AIDS Pandemic. Journal of Public Policy and Marketing, 23 (2), 128–139. CrossrefGoogle Scholar
Lee, J. -Y. & Hunt, P.
(2012) Human Rights Responsibilities of Pharmaceutical Companies in Relation to Access to Medicines. Journal of Law, Medicine and Ethics. Special Issue: SYMPOSIUM: Pharmaceutical Firms and the Right to Health, 40 (2), 220–233. CrossrefGoogle Scholar
Lee, M. & Kohler, J.
(2010) Benchmarking and Transparency: Incentives for Pharmaceutical Industry’s Corporate Social Responsibility. Journal of Business Ethics, 95, 641–658. CrossrefGoogle Scholar
Libenau, J.
(1987) Medical Science and Medical Industry: The Formation of the American Pharmaceutical Industry. London: Macmillan. CrossrefGoogle Scholar
Little, S. & Grieco, M.
(2010) Big Pharma, Social Movements, International Labor, and the Internet: Critical Perspectives in Coordination. Labor History, 51 (1), 71–86. CrossrefGoogle Scholar
Liu, D.
(2008) Linking Adverbials. An Across-Register Corpus Study and its Implications. International Journal of Corpus Linguistics, 13 (4), 491–518. CrossrefGoogle Scholar
Mitchell, R. K., Agle, B. R. & Wood, D. J.
(1997) Toward a Theory of Stakeholder Identification and Salience: Defining the Principle of Who and What Really Counts. Academy of Management Review, 22 (4), 853–886.Google Scholar
O’Dwyer, B.
(2003) Conceptions of Corporate Social Responsibility: The nature of managerial capture. Accounting, Auditing and Accountability Journal, 16 (4), 523–557. CrossrefGoogle Scholar
Oates, S. L. (2001) Generating Multiple Discourse Markers in Text. MPhil Thesis. ITRI: University of Brighton.Google Scholar
Owen, D. & O’Dwyer, B.
(2008) Corporate Social Responsibility: The Reporting and Assurance Dimension. In Crane, A., McWilliams, A., Matten, D., Moon, J. & Seigel, D. (Eds) The Oxford Handbook of Corporate Social Responsibility (pp. 384–409). Oxford: Oxford University Press.Google Scholar
Owen, T.
(2013) From “Pirates” to “Heroes”: News, Discourse Change, and the Contested Legitimacy of Generic HIV/AIDS Medicines. The International Journal of Press/Politics, 18(3), 259–280. CrossrefGoogle Scholar
(2014) The “Access to Medicine” Campaign vs, Big Pharma. Counter-hegemonic Discourse Change and the Political Economy of HIV-AIDS medicines. Critical Discourse Studies, 11 (3), 28–304. CrossrefGoogle Scholar
Perelman, C. & Olbrechts-Tyteca, L.
(1969) The New Rhetoric: A Treatise on Argumentation. Notre Dame / London: University of Notre Dame Press.Google Scholar
Rees, A. van
(2009) Dissociation in Argumentative Discussions. Dordrecht: Springer. CrossrefGoogle Scholar
Rigotti, E. & Rocci, A.
(2005) From Argument Analysis to Cultural Keywords (and Back Again). In van Eemeren, F. H. & Houtlosser, P. (Eds), Argumentation in Practice (pp. 126–142). Amsterdam / Philadelphia: John Benjamins Publishing Company. CrossrefGoogle Scholar
Santoro, M.
(2005) Charting a Sustainable Path for the Twenty-First Century Pharmaceutical Industry. In Santoro, M. / Gorrie, T. (Eds) Ethics and the Pharmaceutical Industry (pp. 1–20). Cambridge: Cambridge University Press. CrossrefGoogle Scholar
Thompson, G. & Hunston, S.
(2000) Evaluation: An Introduction. In S. Hunston & G. Thompson, Evaluation in Text. Authorial Stance and the Construction of Discourse (pp. 1–27). Oxford: Oxford University Press.Google Scholar
WHO / WTO
(2002) WTO Agreements and Public Health: A Joint Study by the WHO and the WTO Secretariat. Geneva, Switzerland: World Health Organization/World Trade Organization.Google Scholar